Glasgow Biomedical Research Centre, 120 University Place, Glasgow G12 8QQ, UK.
Ann Rheum Dis. 2010 Jan;69 Suppl 1:i43-47. doi: 10.1136/ard.2009.120113.
Interleukin 33 (IL33) is a recently described member of the IL1 superfamily of cytokines. Originally defined on the basis of T-cell subset differentiation, IL33 is now recognised to mediate a wider role in regulating components of the innate immune response also, particularly via mast cell activation. In this paper the basic biology of IL33 is described together with that of its cognate receptor, ST2L, and the existing knowledge base for its potential role in mediating human pathology across a range of diseases is defined.
白细胞介素 33(IL33)是最近描述的细胞因子 IL1 超家族的一个成员。最初根据 T 细胞亚群分化定义,IL33 现在被认为在调节先天免疫反应的成分方面也发挥着更广泛的作用,特别是通过肥大细胞的激活。本文描述了 IL33 的基础生物学及其同源受体 ST2L,并确定了其在介导多种疾病的人类病理过程中的潜在作用的现有知识库。